b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="MEDLINE" Owner="NLM">\n        <PMID Version="1">30291558</PMID>\n        <DateCompleted>\n            <Year>2019</Year>\n            <Month>02</Month>\n            <Day>06</Day>\n        </DateCompleted>\n        <DateRevised>\n            <Year>2020</Year>\n            <Month>02</Month>\n            <Day>25</Day>\n        </DateRevised>\n        <Article PubModel="Print-Electronic">\n            <Journal>\n                <ISSN IssnType="Electronic">1865-3774</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>109</Volume>\n                    <Issue>1</Issue>\n                    <PubDate>\n                        <Year>2019</Year>\n                        <Month>Jan</Month>\n                    </PubDate>\n                </JournalIssue>\n                <Title>International journal of hematology</Title>\n                <ISOAbbreviation>Int. J. Hematol.</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>Venous thromboembolism in relapsed or refractory multiple myeloma patients treated with lenalidomide plus dexamethasone.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>79-90</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1007/s12185-018-2540-1</ELocationID>\n            <Abstract>\n                <AbstractText>Lenalidomide plus dexamethasone (LD) is currently the mainstay of treatment for both untreated and relapsed or refractory multiple myeloma (RRMM). Although lenalidomide-associated venous thromboembolism (VTE) is a major clinical concern, its incidence and prognostic impact have not been delineated. In this nationwide retrospective cohort study, we aimed to determine the cumulative incidence of VTE and its prognostic value using two consecutive cohorts of LD-treated RRMM patients: the KMM151 cohort (N\xe2\x80\x89=\xe2\x80\x89542) and the HIRA cohort (N\xe2\x80\x89=\xe2\x80\x891559). Data were collected from medical records for the KMM151 cohort and healthcare insurance claims database for the HIRA cohort. Throughout the study period, 24 patients (4.4%) in the KMM151 cohort and 80 patients (5.1%) in the HIRA cohort developed VTE. The cumulative incidence reached a plateau approximately 2 years after LD initiation. The 2-year incidence was 4.9% in the KMM151 cohort and 8% in the HIRA cohort. Higher starting dose of lenalidomide, previous history of VTE, and older age were associated significantly with an increased VTE risk. Early-onset VTE was associated significantly with poor survival. In conclusion, VTE occurred in 5-8% of RRMM patients treated with LD over 2 years, and early-onset VTE was a strong indicator of poor prognosis.</AbstractText>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Shin</LastName>\n                    <ForeName>Junghoon</ForeName>\n                    <Initials>J</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Division of Hematology-Oncology, Department of Internal Medicine, Seoul National University Bundang Hospital, 82, Gumi-ro 173 Beon-gil, Bundang-gu, Songnam, 13620, Republic of Korea.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Lee</LastName>\n                    <ForeName>Je-Jung</ForeName>\n                    <Initials>JJ</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Internal Medicine, Chonnam National University Hwasun Hospital, Hwasun, Republic of Korea.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Kim</LastName>\n                    <ForeName>Kihyun</ForeName>\n                    <Initials>K</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Internal Medicine, Samsung Medical Center, School of Medicine, Sungkyunkwan University, Seoul, Republic of Korea.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Min</LastName>\n                    <ForeName>Chang-Ki</ForeName>\n                    <Initials>CK</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Division of Hematology, Department of Internal Medicine, Seoul St. Mary\'s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Lee</LastName>\n                    <ForeName>Jeong-Ok</ForeName>\n                    <Initials>JO</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Division of Hematology-Oncology, Department of Internal Medicine, Seoul National University Bundang Hospital, 82, Gumi-ro 173 Beon-gil, Bundang-gu, Songnam, 13620, Republic of Korea.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Suh</LastName>\n                    <ForeName>Cheolwon</ForeName>\n                    <Initials>C</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Kim</LastName>\n                    <ForeName>Jin Seok</ForeName>\n                    <Initials>JS</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Lee</LastName>\n                    <ForeName>Yoo Jin</ForeName>\n                    <Initials>YJ</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Internal Medicine, Kyungpook National University Hospital, Daegu, Republic of Korea.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Yoon</LastName>\n                    <ForeName>Sung-Soo</ForeName>\n                    <Initials>SS</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Jo</LastName>\n                    <ForeName>Jae-Cheol</ForeName>\n                    <Initials>JC</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Internal Medicine, Ulsan University Hospital, Ulsan, Republic of Korea.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Lee</LastName>\n                    <ForeName>Ho Sup</ForeName>\n                    <Initials>HS</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Internal Medicine, Kosin University College of Medicine, Busan, Republic of Korea.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Bang</LastName>\n                    <ForeName>Soo-Mee</ForeName>\n                    <Initials>SM</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Division of Hematology-Oncology, Department of Internal Medicine, Seoul National University Bundang Hospital, 82, Gumi-ro 173 Beon-gil, Bundang-gu, Songnam, 13620, Republic of Korea. smbang7@snu.ac.kr.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <CollectiveName>Korean Multiple Myeloma 151 Investigators</CollectiveName>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <GrantList CompleteYN="Y">\n                <Grant>\n                    <GrantID>KSTH 2016-002</GrantID>\n                    <Agency>Korean Society on Thrombosis and Hemostasis</Agency>\n                    <Country/>\n                </Grant>\n                <Grant>\n                    <GrantID>04-2012-003</GrantID>\n                    <Agency>Seoul National University Bundang Hospital</Agency>\n                    <Country/>\n                </Grant>\n            </GrantList>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2018</Year>\n                <Month>10</Month>\n                <Day>05</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>Japan</Country>\n            <MedlineTA>Int J Hematol</MedlineTA>\n            <NlmUniqueID>9111627</NlmUniqueID>\n            <ISSNLinking>0925-5710</ISSNLinking>\n        </MedlineJournalInfo>\n        <ChemicalList>\n            <Chemical>\n                <RegistryNumber>7S5I7G3JQL</RegistryNumber>\n                <NameOfSubstance UI="D003907">Dexamethasone</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>F0P408N6V4</RegistryNumber>\n                <NameOfSubstance UI="D000077269">Lenalidomide</NameOfSubstance>\n            </Chemical>\n        </ChemicalList>\n        <CitationSubset>IM</CitationSubset>\n        <MeshHeadingList>\n            <MeshHeading>\n                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000971" MajorTopicYN="N">Antineoplastic Combined Chemotherapy Protocols</DescriptorName>\n                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D003907" MajorTopicYN="N">Dexamethasone</DescriptorName>\n                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000077269" MajorTopicYN="N">Lenalidomide</DescriptorName>\n                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D009101" MajorTopicYN="N">Multiple Myeloma</DescriptorName>\n                <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>\n                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>\n                <QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D016879" MajorTopicYN="N">Salvage Therapy</DescriptorName>\n                <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D016019" MajorTopicYN="N">Survival Analysis</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D054556" MajorTopicYN="N">Venous Thromboembolism</DescriptorName>\n                <QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName>\n            </MeshHeading>\n        </MeshHeadingList>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="N">Incidence</Keyword>\n            <Keyword MajorTopicYN="N">Lenalidomide</Keyword>\n            <Keyword MajorTopicYN="N">Multiple myeloma</Keyword>\n            <Keyword MajorTopicYN="N">Survival</Keyword>\n            <Keyword MajorTopicYN="N">Venous thromboembolism</Keyword>\n        </KeywordList>\n        <InvestigatorList>\n            <Investigator ValidYN="Y">\n                <LastName>Lee</LastName>\n                <ForeName>Jeong-Ok</ForeName>\n                <Initials>JO</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Bang</LastName>\n                <ForeName>Soo-Mee</ForeName>\n                <Initials>SM</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Lee</LastName>\n                <ForeName>Je-Jung</ForeName>\n                <Initials>JJ</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Kim</LastName>\n                <ForeName>Kihyun</ForeName>\n                <Initials>K</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Min</LastName>\n                <ForeName>Chang-Ki</ForeName>\n                <Initials>CK</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Suh</LastName>\n                <ForeName>Cheolwon</ForeName>\n                <Initials>C</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Yoon</LastName>\n                <ForeName>Dok Hyun</ForeName>\n                <Initials>DH</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Kim</LastName>\n                <ForeName>Jin Seok</ForeName>\n                <Initials>JS</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Jin</LastName>\n                <ForeName>Yoo</ForeName>\n                <Initials>Y</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Moon</LastName>\n                <ForeName>Joon Ho</ForeName>\n                <Initials>JH</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Yoon</LastName>\n                <ForeName>Sung-Soo</ForeName>\n                <Initials>SS</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Kim</LastName>\n                <ForeName>Inho</ForeName>\n                <Initials>I</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Jo</LastName>\n                <ForeName>Jae-Cheol</ForeName>\n                <Initials>JC</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Lee</LastName>\n                <ForeName>Ho Sup</ForeName>\n                <Initials>HS</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Park</LastName>\n                <ForeName>Seong Kyu</ForeName>\n                <Initials>SK</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Shin</LastName>\n                <ForeName>Ho-Jin</ForeName>\n                <Initials>HJ</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Kim</LastName>\n                <ForeName>Min Kyoung</ForeName>\n                <Initials>MK</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Mun</LastName>\n                <ForeName>Yeung-Chul</ForeName>\n                <Initials>YC</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Lee</LastName>\n                <ForeName>Mark Hong</ForeName>\n                <Initials>MH</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Park</LastName>\n                <ForeName>Yong</ForeName>\n                <Initials>Y</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Eom</LastName>\n                <ForeName>Hyeon Seok</ForeName>\n                <Initials>HS</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Kim</LastName>\n                <ForeName>Hyo Jung</ForeName>\n                <Initials>HJ</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Im</LastName>\n                <ForeName>Sung Nam</ForeName>\n                <Initials>SN</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Kim</LastName>\n                <ForeName>Sung-Hyun</ForeName>\n                <Initials>SH</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Do</LastName>\n                <ForeName>Young Rok</ForeName>\n                <Initials>YR</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Lee</LastName>\n                <ForeName>Won Sik</ForeName>\n                <Initials>WS</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Cho</LastName>\n                <ForeName>Su Hee</ForeName>\n                <Initials>SH</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Yi</LastName>\n                <ForeName>Jun Ho</ForeName>\n                <Initials>JH</Initials>\n            </Investigator>\n            <Investigator ValidYN="Y">\n                <LastName>Lee</LastName>\n                <ForeName>Jae Hoon</ForeName>\n                <Initials>JH</Initials>\n            </Investigator>\n        </InvestigatorList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2018</Year>\n                <Month>08</Month>\n                <Day>09</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2018</Year>\n                <Month>09</Month>\n                <Day>19</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="revised">\n                <Year>2018</Year>\n                <Month>09</Month>\n                <Day>17</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2018</Year>\n                <Month>10</Month>\n                <Day>7</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2019</Year>\n                <Month>2</Month>\n                <Day>7</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2018</Year>\n                <Month>10</Month>\n                <Day>7</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">30291558</ArticleId>\n            <ArticleId IdType="doi">10.1007/s12185-018-2540-1</ArticleId>\n            <ArticleId IdType="pii">10.1007/s12185-018-2540-1</ArticleId>\n        </ArticleIdList>\n        <ReferenceList>\n            <Reference>\n                <Citation>Arch Intern Med. 2002 May 27;162(10):1182-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">12020191</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Clin Oncol. 2006 Jan 20;24(3):431-6</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">16365178</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>N Engl J Med. 2007 Nov 22;357(21):2123-32</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">18032762</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>N Engl J Med. 2007 Nov 22;357(21):2133-42</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">18032763</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Leukemia. 2008 Feb;22(2):414-23</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">18094721</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer. 2008 Apr 1;112(7):1522-8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">18278812</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Blood. 2008 Dec 15;112(13):4924-34</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">18805967</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Thromb Res. 2009 Mar;123(5):679-86</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">18992924</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Br J Haematol. 2009 Jul;146(2):164-70</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19545290</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Leukemia. 2009 Nov;23(11):2147-52</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19626046</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Ann Hematol. 2010 Feb;89(2):201-6</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19705118</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Lancet Oncol. 2010 Jan;11(1):29-37</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19853510</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Clin Oncol. 2010 Jan 1;28(1):132-5</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19901114</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Thromb Haemost. 2011 Jan;9(1):85-91</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20942850</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Thromb Haemost. 2011 Apr;9(4):653-63</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21255254</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Ann Hematol. 2012 Nov;91(11):1773-8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22706703</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Ann Hematol. 2014 Jan;93(1):113-21</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24026427</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Diabetes Metab J. 2014 Oct;38(5):395-403</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25349827</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>N Engl J Med. 2015 Jan 8;372(2):142-52</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25482145</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Blood Res. 2015 Mar;50(1):7-18</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25830125</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>N Engl J Med. 2016 Apr 28;374(17):1621-34</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27119237</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>N Engl J Med. 2016 Aug 25;375(8):754-66</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27557302</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>N Engl J Med. 2016 Oct 6;375(14):1319-1331</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27705267</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Lancet. 2017 Feb 4;389(10068):519-527</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28017406</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Natl Compr Canc Netw. 2017 Feb;15(2):230-269</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28188192</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Korean Med Sci. 2017 May;32(5):718-728</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28378543</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>PLoS One. 2018 Jan 25;13(1):e0191897</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29370290</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Clin Oncol. 1983 Nov;1(11):710-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">6668489</ArticleId>\n                </ArticleIdList>\n            </Reference>\n        </ReferenceList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'